Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
about
New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus MefloquineDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaA randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malariaPopulation pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patientsDeployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria InitiativeOpen-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malariaPyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trialThe role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011Injections, cocktails and diviners: therapeutic flexibility in the context of malaria elimination and drug resistance in Northeast CambodiaAuditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.Reaction of artemisinin with haemoglobin: implications for antimalarial activity.Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malariaThiamin supplementation does not reduce the frequency of adverse events after anti-malarial therapy among patients with falciparum malaria in southern Laos.Natural products as promising drug candidates for the treatment of hepatitis B and C.Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT intervalThe story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial GuineaAssessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.Subchronic toxicological study of two artemisinin derivatives in dogsEfficacy and effectiveness of mefloquine and artesunate combination therapy for uncomplicated Plasmodium falciparum malaria in the Peruvian Amazon.Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults.Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in SenegalBlackwater fever in children, Burundi.The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trialAmodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial.In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in VietnamThe neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.In-vitro Evaluation of Antileishmanial Activity and Toxicity of Artemether with Focus on its Apoptotic Effect.Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine.Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.Neurotoxic mode of action of artemisinin.
P2860
Q22061804-7C97D1FA-DB06-4BCC-86BE-CDC763C1DB36Q24201077-5A705CDB-4FAF-4180-9143-9D00C645638BQ24814579-A541A4AA-518F-4E58-B983-BE109FC4201CQ28365926-092A03F5-D49A-49DD-AAA5-5F4D066C6AE3Q28469076-4FB58488-0657-495A-8343-CA0273F05787Q28469264-C3B87EE0-2802-49E8-BB12-18DEA35F84F5Q28472247-27EA82C3-275C-45CD-918E-25EAB7691309Q28476754-DB4D030E-831E-4E7C-B151-15FBB90B91ECQ28487960-4E02E59D-60D8-44F4-AED8-CD4AB9DC59ABQ28534978-EBA04B49-BE66-4A8D-8CA8-B5B5ED5C0090Q30492414-3527D767-2D7B-48D8-A695-84F4FB3376CEQ30592761-749A5804-39F1-49C9-B97B-3E97538E2829Q31150958-8994DB38-1A44-424B-B001-3E298F13B53AQ33206718-CF32A596-687C-4E59-AEBD-EB7EE12D0F73Q33745061-A9D687B7-915D-479E-B565-DA334DB729E8Q33806574-8BBAADEF-E59C-4972-979E-C7A62715C5ADQ33880614-5868870F-6EDF-479E-B501-FF54F1A05529Q33929242-781BB878-D0E8-48E6-8860-6DBA98DBF205Q34015041-981F10A2-BA64-48D8-B1A3-DF37E3E7FE82Q34298973-092C0CEE-FA48-4620-AA74-1832D78AB9CCQ34329292-018EA302-4D4A-446E-A763-6C450BAA94D5Q34562754-7A6C5114-7B45-4383-962A-5F4763E37322Q34716441-522A2D1E-D2C8-4B23-8F4C-DB667E1C0033Q34939414-BDE26364-FA80-40AC-9614-2C3FECCDFCADQ35150376-AE8B0AE5-B02E-49D4-B10B-271D99CBB94DQ35186891-903771F4-9291-48DE-807A-4AC21A7AFC8DQ35363936-3AFB6582-F54D-4F5F-A808-AF1B7EC11998Q35829744-781035C0-B8E6-4F12-9415-46E68510B408Q35891353-DC5091B8-AABD-46BE-A6B8-11A311B10AF8Q36021965-9F6375CB-06CB-4AAF-A1C1-43B3DF48ABCDQ36138872-DCE9A27D-40FB-4CB6-9151-4F488BB83D27Q36594406-04B7143F-5529-401D-9B83-DEA8CA0B1C5DQ36782415-C3FEBEB1-DF32-49E8-9C31-B43BAF2869E9Q36919824-2D961AE3-00E0-4A4F-AB70-B95DFDE4324EQ37094433-2EFE292F-215A-4A2A-A87D-7D2880F4DBC4Q37346189-2557CD4F-6F01-4C09-915D-1C12333F1626Q37576984-4C1EC4F8-421D-417E-A746-5E34BC9FC32CQ38372007-D5FC6030-FDC0-4E86-894F-384F50640860Q38684764-755A11BB-CC59-4469-8EF7-4EAB49CFBDD5Q39653002-436D830C-033F-44A1-B54D-1FED132A7555
P2860
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Adverse effects in patients wi ...... with artemisinin derivatives.
@ast
Adverse effects in patients wi ...... with artemisinin derivatives.
@en
type
label
Adverse effects in patients wi ...... with artemisinin derivatives.
@ast
Adverse effects in patients wi ...... with artemisinin derivatives.
@en
prefLabel
Adverse effects in patients wi ...... with artemisinin derivatives.
@ast
Adverse effects in patients wi ...... with artemisinin derivatives.
@en
P2093
P921
P1476
Adverse effects in patients wi ...... with artemisinin derivatives.
@en
P2093
C Luxemburger
F ter Kuile
M van Vugt
R McGready
T Chongsuphajaisiddhi
P304
P407
P577
1999-04-01T00:00:00Z